Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 4
1974 2
1975 1
1976 6
1977 2
1978 4
1979 2
1980 3
1981 2
1982 3
1983 1
1985 1
1986 1
1988 6
1989 3
1990 5
1991 3
1992 4
1993 1
1994 3
1995 1
1996 2
1997 6
1998 4
1999 6
2000 3
2001 3
2002 1
2003 4
2004 2
2005 4
2006 5
2007 7
2008 5
2009 3
2010 8
2011 4
2012 6
2013 4
2014 3
2015 7
2016 5
2017 7
2018 8
2019 6
2020 9
2021 9
2022 10
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Results by year

Filters applied: . Clear all
Page 1
[Cryoglobulinemia].
Ottl T, Trendelenburg M. Ottl T, et al. Among authors: trendelenburg m. Ther Umsch. 2008 May;65(5):253-8. doi: 10.1024/0040-5930.65.5.253. Ther Umsch. 2008. PMID: 18622928 Review. German.
Complement C1q Enhances Primary Hemostasis.
Donat C, Kölm R, Csorba K, Tuncer E, Tsakiris DA, Trendelenburg M. Donat C, et al. Among authors: trendelenburg m. Front Immunol. 2020 Jul 16;11:1522. doi: 10.3389/fimmu.2020.01522. eCollection 2020. Front Immunol. 2020. PMID: 32765527 Free PMC article.
Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus.
Kleer JS, Rabatscher PA, Weiss J, Leonardi J, Vogt SB, Kieninger-Gräfitsch A, Chizzolini C, Huynh-Do U, Ribi C, Trendelenburg M. Kleer JS, et al. Among authors: trendelenburg m. Front Immunol. 2022 Jan 11;12:761395. doi: 10.3389/fimmu.2021.761395. eCollection 2021. Front Immunol. 2022. PMID: 35087514 Free PMC article.
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Urwyler P, Leimbacher M, Charitos P, Moser S, Heijnen IAFM, Trendelenburg M, Thoma R, Sumer J, Camacho-Ortiz A, Bacci MR, Huber LC, Stüssi-Helbling M, Albrich WC, Sendi P, Osthoff M. Urwyler P, et al. Among authors: trendelenburg m. Front Immunol. 2023 Oct 27;14:1255292. doi: 10.3389/fimmu.2023.1255292. eCollection 2023. Front Immunol. 2023. PMID: 37965347 Free PMC article. Clinical Trial.
Organization of transcribed and nontranscribed chromatin.
Franke WW, Scheer U, Zentgraf H, Trendelenburg MF, Müller U, Krohne G, Spring H. Franke WW, et al. Among authors: trendelenburg mf. Results Probl Cell Differ. 1980;11:15-36. doi: 10.1007/978-3-540-38267-6_3. Results Probl Cell Differ. 1980. PMID: 7003670 Review. No abstract available.
Complement Activation Is Associated With Disease Severity in Multiple Sclerosis.
Oechtering J, Stein K, Schaedelin SA, Maceski AM, Orleth A, Meier S, Willemse E, Qureshi F, Heijnen I, Regeniter A, Derfuss T, Benkert P, D'Souza M, Limberg M, Fischer-Barnicol B, Achtnichts L, Mueller S, Salmen A, Lalive PH, Bridel C, Pot C, Du Pasquier RA, Gobbi C, Wiendl H, Granziera C, Kappos L, Trendelenburg M, Leppert D, Lunemann JD, Kuhle J; Swiss MS Cohort Study. Oechtering J, et al. Among authors: trendelenburg m. Neurol Neuroimmunol Neuroinflamm. 2024 Mar;11(2):e200212. doi: 10.1212/NXI.0000000000200212. Epub 2024 Feb 14. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38354323 Free article.
202 results